Media

29 Jun 2022

JIXING Announces Receipt of Clinical Trial Application Approval for China Cohort of Phase 3 Clinical Trial of Aficamten

Read article

09 May 2022

Hovione and JIXING Announce an Exclusive Global License Agreement for Ophthalmology Program

Read article

20 Apr 2022

JIXING Announces Leadership Transition

Read article

14 Apr 2022

LENZ Therapeutics and JIXING Announce an Exclusive Greater China License Agreement; RTW to Invest in LENZ Therapeutics

Read article

31 Mar 2022

JIXING Announces the Appointment of Kun Wu as the Chief Commercial Officer

Read article

21 Mar 2022

JIXING Announces Receipt of Clinical Trial Application Approval for OC-01 Nasal Spray Phase 3 Trial for the Treatment of Signs and Symptoms of Dry Eye Diseases in China

Read article